|国家科技期刊平台
首页|期刊导航|中国药物经济学|基于病案首页的老年支气管炎患者住院费用影响因素分析

基于病案首页的老年支气管炎患者住院费用影响因素分析OA

Influencing Factors of Hospitalisation Costs in Bronchitis Patients based on the First Page of Medical Records

中文摘要英文摘要

目的 探讨60 岁及以上老年支气管炎患者住院费用的影响因素,为控制住院费用,减轻患者及家庭经济负担提供建议.方法 收集 2006 年 1 月至 2019 年 12 月重庆市两家三甲医院 60 岁及以上老年支气管炎住院患者病案首页信息,采用单因素分析、多元线性回归和分类回归树模型分析住院费用的影响因素.结果 药物费在总住院费用中的构成比呈逐年降低趋势,检查费的构成比逐渐增加.多元线性回归分析结果显示患者住院费用的影响因素有14 个,包括性别、抢救、住院时间、输血、特殊护理和手术等,其中医院内感染、住院时间和输血对费用的影响较为显著.结论 控制老年支气管炎患者住院费用的重点应集中于检查费用.减少医院内感染,缩短住院时间,鼓励无偿献血保障血液供应有助于降低住院费用.

Objective To determine the influencing factors of hospitalisation costs for old bronchitis patients with aged 60 and above and to formulate scientific and reasonable medical cost control measures and reduce the economic burden of patients and families.Methods The first page of medical records information for old bronchitis patients aged 60 and above from January 2006 to December 2019 was collected from two third class hospitals in Chongqing.Factors associated with hospitalisation costs were analysed using univariate analyses,multiple linear regressions,and classfication regression tree.Results The constituent ratio of drug cost in the total hospitalization costs decreased year by year,and the constituent ratio of examination cost increased gradually.Multiple linear regression analysis showed that there were 16 influencing factors of hospitalization costs of bronchitis patients,including gender,rescue,length of stay,blood transfusion,special care and surgery,among which nosocomial infection,length of stay,and blood transfusion have a significant impact on the cost.Conclusion The key point of controlling the hospitalization costs of old bronchitis patients should focus on the examination expenses.Reducing nosocomial infection,shortening length of stay,and encourage blood donation will be helpful to reduce hospitalization costs.

蒋跃旭;郭远林

贵阳市第一人民医院医务科,贵阳 550002国药医疗健康产业有限公司,北京 100029

临床医学

支气管炎住院费用多元线性回归分类回归树

BronchitisHospitalisation costsMultiple linear regressionClassfication Regression Tree

《中国药物经济学》 2024 (006)

12-18,24 / 8

10.12010/j.issn.1673-5846.2024.06.002

评论